How to Buy Cellectar Biosciences Stock

Cellectar Biosciences Inc

Cellectar Biosciences, Inc. , a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer.

Cellectar Biosciences stock last closed at $0.29, down 3.01% from the previous day, and has decreased 90.91% in one year. It has underperformed other stocks in the Biotechnology industry by 0.13 percentage points. Cellectar Biosciences stock is currently +29.46% from its 52-week low of $0.22, and -91.74% from its 52-week high of $3.51.

At the moment, there are 46.08M shares of CLRB outstanding. The market capitalization of CLRB is $13.36M. In the past 24 hours, 893,768 CLRB shares were traded.

How to Buy Cellectar Biosciences Stock

Not sure how to invest in Cellectar Biosciences stock? Here's how.

  1. Choose where to buy Cellectar Biosciences stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you choose where to buy Cellectar Biosciences stock.
  2. Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Fund your investment account: Select your method of payment and add your information.
  4. Analyze Cellectar Biosciences stock: The Cellectar Biosciences ticker symbol is CLRB. Is Cellectar Biosciences stock a good investment? Should you buy shares of CLRB? How do CLRB's underlying business fundamentals look? Do top analysts think Cellectar Biosciences is a good buy? Why has CLRB's stock price moved recently? (Hint: Our stock market research website can help you understand if CLRB is a good stock to buy).
  5. Place your CLRB trade: Decide if you will purchase CLRB shares at the current market price or use a limit order to purchase CLRB shares at a given price.
  6. Track your CLRB position: Create a watchlist to important notifications about your investment in Cellectar Biosciences shares.

Step 1: Choose where to buy Cellectar Biosciences stock

You need an online brokerage account in order to access the NASDAQ market and buy CLRB shares.

A brokerage account allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

We believe that eToro is the best brokerage. Here's why:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to global financial markets: From Tech to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've selected the best brokerage, you need to fill out some personal details so you can buy CLRB stock today.

How to Start a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal info to open a new trading account.
  1. Send your details by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you have filled out your info on the best stock market app, you need to deposit funds:

Check out the walkthrough below if you need help transferring money into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Cellectar Biosciences stock

After you have identified the best place to buy Cellectar Biosciences stock, it's important to research their stock prior to buying, so you truly understand the risk and opportunity.

Cellectar Biosciences Numbers

CLRB Price
$0.29
1w %
-1.36%
1y %
-90.91%
5y %
-97.82%
P/E
-0.24x
P/B
0.93x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$44.58M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$13.36M
Next Earnings
May 12, 2025
Next Dividend
N/A

CLRB Fundamentals

WallStreetZen was created to help everyday investors do more in-depth fundamental analysis quickly.

You can view all of the due diligence checks on CLRB's stock page.

Is CLRB stock overvalued?

Analysts use many financial metrics, analyses, models, and charts to gauge CLRB's fair value.

Using relative valuations metrics:

  • CLRB may be undervalued based on its P/B ratio of 0.93x, relative to Biotechnology industry P/B ratio of 4.04x

You can do more valuation analysis on CLRB's stock here.

A look at CLRB Cashflows and Balance Sheet

Passed Health Checks:

  • There are more short-term assets than short-term liabilities on the CLRB balance sheet.
  • There are more short-term assets than long-term liabilities on the CLRB balance sheet.

Failed Health Checks:

  • Total CLRB debt is higher than 5 years ago, relative to shareholder equity.
  • CLRB has a relatively high debt to equity ratio of 0.69.
  • CLRB has $23.29M in cash and short term investments. This is not sufficient to cover its annual cash burn of $47.69M.
  • CLRB has cash burn of 47687196. It does not have sufficient cash and short-term investments to cover this.

Is it a good time to buy Cellectar Biosciences stock, according to Wall Street analysts?

Out of 1 sell side analysts who give ratings on CLRB, the consensus analyst rating on Cellectar Biosciences is a Buy

It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.

You can dig deeper into what analysts are projecting on the Cellectar Biosciences stock forecast page.

CLRB Trading Indicators

SMA10
0.27
SMA20
0.3
SMA50
0.31
SMA100
0.43
SMA200
1.28
MACD
-0.01
MACD Signal
-0.01
MACD Histogram
0
RSI
46.84
Stochastic %K
53.63
Stochastic %D
47.18
StochRSI %K
88.06
StochRSI %D
79.41

What are CLRB executives and large shareholders up to?

Over the past 12 months, executives and large shareholders at CLRB have bought more shares than they have sold.

Jarrod Longcor, Chief Operating Officer of CLRB, was the latest CLRB insider to buy. They bought $8,400.00 worth of CLRB shares on Jan 10, 2025.

Learn more about who owns CLRB stock here.

Does CLRB stock generate passive income?

No, Cellectar Biosciences doesn't provide an income stream by paying out dividends.

Get analysis from other investors

One of the reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to see what other community members have to say.

Step 5: Place your CLRB trade

You have two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are usually sufficient.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at a given dollar amount limit, use a limit order.

Press the Open button and your broker will place the order.

If you want more help investing in stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Track your CLRB position

Now that you own some shares in CLRB, you'll want to stay up-to-date on your shares.

Add CLRB to a watchlist to get notified of important updates regarding your CLRB stock.

CLRB Feed

How to Buy Stock in Cellectar Biosciences

To reiterate, here are the 6 steps you need to take to buy Cellectar Biosciences stock right now:

  1. Choose where to buy Cellectar Biosciences stock
  2. Open your brokerage account
  3. Fund your investment account
  4. Analyze Cellectar Biosciences stock
  5. Place your CLRB trade
  6. Track your CLRB position

If you need a online brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to monitor your investment in Cellectar Biosciences, click below.

NASDAQ: CLRB
$0.29-0.01 (-3.01%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: CLRB
$0.29-0.01 (-3.01%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Cellectar Biosciences share?

As of Apr 21, 2025, it costs $0.29 to buy one share of Cellectar Biosciences stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.15, you can buy 0.5 shares of CLRB.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Cellectar Biosciences stock?

According to 1 Wall Street analysts who monitor Cellectar Biosciences, their consensus recommendation is to buy Cellectar Biosciences stock.

What is the best way to buy Cellectar Biosciences stock?

One way to place an order for Cellectar Biosciences stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.